Interní Med. 2010; 12(10): 482-486 [Onkologie. 2010:4(2):94-100]

Breakthrough pain and it’s treatment

MUDr.Pavlína Nosková
Centrum léčby bolesti KARIM VFN a 1. LF UK Praha

Breakthrough pain (BP) is defined as transitory pain that occurs on a background of relatively well controlled baseline pain. This pain character

can join pain of tumour disease origin but not only that one. Question to specify the character of pain should be common in daily contact

with a patient. To resolve this problem it seems neccessary to provide patients wit rescue mediation with rapid 30 minute onset. The article

comes with analgetics review according to WHO classificaton and suitable for BP and available in the Czech republic. From the point of fast

onset view we are looking for new approaches and application routs practical also for outpatient departments. Intranasal fentanyl offers

such option. When pharmacotherapy is not effective any more, mainly in oncology new invasive methods are being explored.

Keywords: breakthrough pain (BP), rescue medication, Oxford league of analgesics, invasive procedures, nasal spray

Published: November 15, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P. Breakthrough pain and it’s treatment. Interní Med. 2010;12(10):482-486.
Download citation

References

  1. Caraceni A, et al. Portenoy RK, and a Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliative Medicine 2004; 18: 177-183. Go to original source... Go to PubMed...
  2. Davies A. Introduction. In Davies A. editor. Cancer-related Breakthrough Pain. Oxford Pain management library: Oxford University Press; 2007: 7. Go to original source...
  3. Lauterburg BH. Analgesics and glutathione. Am. J. Ther. 2002; 9: 225-233. Go to original source... Go to PubMed...
  4. Kršiak M. Farmakoterapie bolestí zad. Bolest 2007; 10(1): 14.
  5. Kršiak M. Analgetická kombinace paracetamolu s tramadolem. Farmakoterapie 2005; 3: 208-211.
  6. Christrup, et al. Clin Ther 2008; 30(3): 469-481.
  7. Kaasa, et al. The efficacy of intranasal fentanyl spray treatment of breakthrough pain in cancer patients evaluated in a randomised double blind study. Poster presented at World Congress on Pain, 2008.
  8. Popper, et al. The efficacy of intranasal fentanyl spray treatment of breakthrough pain in cancer patients evaluated in a randomised double blind study. Poster presented at World Congress on Pain, 2008.
  9. Mercandante S, Radfbruch L, Davies A, et al. A comparison of ontranasal fentanyl spray with oral transmucosal fentanyl citrat for the treatment of breaktrough cancer pain. Curr Med Res Opin. 2009; 25: 2805-2815. Go to original source... Go to PubMed...
  10. Metodické pokyny pro farmakoterapii nádorové bolesti SSLB update 2009.
  11. Metodické pokyny pro farmakoterapii akutní a chronické nenádorové bolesti SSLB update 2009.
  12. Portenoy RK, Hagen NA. Breaktrough pain: definition, prevalence and characteristics. Pain 1190; 41: 273-281. Go to original source...
  13. Vondráčková D. Nové cesty léčení průlomové bolesti. Bolest 2009; 12(3): 153-160.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.